| Literature DB >> 32714179 |
Cheng Zhou1, Ting Gao2, Tao Guo1, Jingjing Wu1, Xiaojun Guan1, Weiwen Zhou3, Peiyu Huang1, Min Xuan1, Quanquan Gu1, Xiaojun Xu1, Shunren Xia4, Dexing Kong5, Jian Wu6, Minming Zhang1.
Abstract
Purpose: To investigate the structural covariance network disruption in Parkinson's disease (PD), and explore the functional alterations of disrupted structural covariance network.Entities:
Keywords: Parkinson’s disease; blood oxygen level-dependent; independent component analysis; magnetic resonance imaging; neural network
Year: 2020 PMID: 32714179 PMCID: PMC7351504 DOI: 10.3389/fnagi.2020.00199
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Figure 1Flaw chart. The blue part of this image depicted the participant’s screening workflow and the results of structural covariance network analysis. Parkinson’s disease (PD) patients showed decreased structural covariance between anterior and posterior cingulate subnetworks. The orange part of this image depicted the flow and results of functional network analysis. The goodness of fit analysis was used to seek the functional network showed high spatial overlap with cingulate structural covariance network. Functional Network Connectivity (FNC) analysis showed increased connectivity between anterior and posterior cingulate network. The gray part of this image depicted the results of longitudinal validation. PD patients showed increased cingulate structural network disruption during follow-up, while the FNC increased first and decreased at last. Red curve, functional connectivity change; Blue curve, structural integrity change; Green-line, healthy control, Black-line, the two time-points in our data.
Demographic characteristic.
| Controls ( | PD patients ( | ||
|---|---|---|---|
| Age | 59.76 ± 7.63 | 59.77 ± 9.08 | 0.994 |
| Sex (male/female) | 30/47 | 55/45 | 0.121 |
| Education | 9.09 ± 3.57 | 8.15 ± 4.45 | 0.146 |
| Duration | - | 2.82 ± 1.74 | - |
| H-Y stage | - | 1.85 ± 0.64 | - |
| UPDRS I | - | 1.23 ± 1.45 | - |
| UPDRS II | - | 8.96 ± 5.21 | - |
| UPDRS III | - | 25.26 ± 22.27 | - |
| UPDRS IV | - | 0.96 ± 4.97 | - |
| UPDRS total | - | 36.05 ± 18.78 | - |
| PDQ-39 | - | 24.18 ± 19.48 | - |
| MMSE | 27.93 ± 2.14 | 26.98 ± 3.42 | 0.053 |
H-Y, Hoehn-Yahr; UPDRS, Unified Parkinson’s Disease Rating Scale; PDQ-39, Parkinson’s Disease Questionnaire (39 questions); MMSE, Mini-Mental State Examination.
Demographics characteristics between PD patients in cross-sectional and longitudinal cohorts.
| PD in the whole group (100) | PD in the longitudinal subgroup (51) | ||
|---|---|---|---|
| Age | 59.77 ± 9.08 | 60.49 ± 8.19 | 0.635 |
| Sex (male/female) | 55/45 | 30/21 | 0.657 |
| Education | 8.15 ± 4.45 | 8.69 ± 4.46 | 0.490 |
| Duration | 2.82 ± 1.74 | 3.06 ± 2.00 | 0.441 |
| H-Y stage | 1.85 ± 0.64 | 1.96 ± 0.49 | 0.274 |
| UPDRS I | 1.23 ± 1.45 | 1.10 ± 1.14 | 0.571 |
| UPDRS II | 8.96 ± 5.21 | 8.18 ± 4.27 | 0.355 |
| UPDRS III | 25.26 ± 22.27 | 22.27 ± 12.03 | 0.200 |
| UPDRS IV | 0.96 ± 4.97 | 0.67 ± 1.34 | 0.680 |
| UPDRS total | 36.05 ± 18.78 | 32.41 ± 16.03 | 0.239 |
| PDQ-39 | 24.18 ± 19.48 | 21.72 ± 17.57 | 0.453 |
| MMSE | 26.98 ± 3.42 | 27.75 ± 2.77 | 0.170 |
H-Y, Hoehn-Yahr; UPDRS, Unified Parkinson’s Disease Rating Scale; PDQ-39, Parkinson’s Disease Questionnaire (39 questions); MMSE, Mini-Mental State Examination.
Demographics characteristics in the longitudinal subgroup.
| PD patients at baseline (51) | PD patients at follow-up (51) | Controls (70) | |||||
|---|---|---|---|---|---|---|---|
| A | B | C | D | ||||
| Age | 60.49 ± 8.19 | 62.45 ± 8.11 | 59.76 ± 7.63 | 0.179 | - | - | - |
| Sex (male/female) | 30/21 | 30/21 | 30/47 | 0.121 | - | - | - |
| Education | 8.69 ± 4.46 | 8.69 ± 4.46 | 9.09 ± 3.57 | 0.451 | - | - | - |
| Duration | 3.06 ± 2.00 | 5.02 ± 1.92 | - | - | - | - | - |
| H-Y stage | 1.96 ± 0.49 | 2.15 ± 0.52 | - | - | 0.066 | - | - |
| UPDRS I | 1.10 ± 1.14 | 1.63 ± 1.95 | - | - | 0.097 | - | - |
| UPDRS II | 8.18 ± 4.27 | 7.78 ± 5.14 | - | - | 0.676 | - | - |
| UPDRS III | 22.27 ± 12.03 | 18.49 ± 10.48 | - | - | 0.007 | - | - |
| UPDRS IV | 0.67 ± 1.34 | 1.16 ± 1.29 | - | - | 0.062 | - | - |
| UPDRS total | 32.41 ± 16.03 | 29.06 ± 14.89 | - | - | 0.093 | - | - |
| PDQ-39 | 21.72 ± 17.57 | 23.32 ± 20.68 | - | - | 0.678 | - | - |
| MMSE | 27.75 ± 2.77 | 27.45 ± 2.72 | 27.93 ± 2.14 | 0.588 | - | - | - |
H-Y, Hoehn-Yahr; UPDRS, Unified Parkinson’s Disease Rating Scale; PDQ-39, Parkinson’s Disease Questionnaire (39 questions); MMSE, Mini-Mental State Examination; A, ANOVA; B, Paired .
Figure 2Structural covariance networks changes in PD patients. PD patients showed decreased integrity in the frontoparietal structural network and cingulate structural network (IC 4 and IC11).
Figure 3Decreased covariance between anterior and posterior cingulate structural subnetworks in PD patients. The posterior cingulate gyrus was not express in the cingulate network but expressed in the frontoparietal network which indicates the decreased covariance between anterior and posterior cingulate structural subnetworks.
Altered structural networks in PD patients.
| Networks Brain regions | Brain regions | Voxel size | MNI coordinates | ||
|---|---|---|---|---|---|
| | |||||
| Anterior cingulate cortex and superior and middle frontal cortex | 21,376 | 35 | 27 | 38 | |
| Posterior cingulate cortex, precuneus and angular | 6,948 | 27 | −53 | 50 | |
| | |||||
| Precentral, postcentral gyri and inferior parietal gyri | 23,541 | 59 | −18 | 30 | |
| | |||||
| Anterior cingulate cortex and superior and middle frontal cortex | 29,015 | −36 | 23 | 41 | |
| | |||||
| Precentral, postcentral gyri, inferior parietal gyri and angular | 18,620 | 45 | −59 | 33 | |
| Posterior cingulate cortex and precuneus | 6,127 | 8 | −53 | 41 | |
MNI, Montreal Neurological Institute.
Figure 4Goodness-of-fit (GOF) analysis between structural and functional networks. GOF was defined as the difference between the t-score mean within vs. outside structural network template. Orange dots represent the GOF score of the functional independent components (ICs) showed the highest similarity with the anterior and posterior cingulate structural subnetworks. Blue dots represent the GOF score of other functional ICs. GOF score was calculated in healthy controls (A) and patients (B), respectively.
Figure 5FNC in patients and healthy controls. (A) Anterior and posterior cingulate functional network in healthy controls and PD patients (Family wise error, FWE corrected, p = 0.001). (B) The changes of FNC between the anterior and posterior cingulate functional network in healthy controls and PD patients.
Figure 6Association between structural network integrity and the strength of FNC.
Figure 7Longitudinal change of FNC.